Some of the world’s largest drugmakers are joining forces with rivals to help produce Covid-19 vaccines, forging unusual alliances that promise to dramatically increase supplies by this summer.
Normally, the big pharmaceutical companies compete with each other to sell cancer, arthritis and other drugs. The desperate need for Covid-19 vaccines, however, is turning the industry’s fierce competitors into friends of a rapid pandemic.
Sanofi SA recently agreed to help manufacture a vaccine from Pfizer Inc. and its partner BioNTech SE after Sanofi’s investigational Covid-19 vaccine suffered a five-month setback, freeing a production line in Frankfurt.
“We were looking to help,” said Thomas Triomphe, executive vice president for vaccines at Sanofi, which will begin in June with a crucial final step to manufacture 125 million doses.
Novartis AG has also agreed to help Pfizer and BioNTech produce more doses, while Baxter International Inc. and Endo International PLC have agreed to help Novavax Inc. produce its injection.